HPV is the wild card - ssb have factored into their 12 month estimate of $41 plus a gain of 15 - 20 million in 2nd half 2006 for HPV royalities.
Your post :
This year (FY 05) profit will be above $500m with a oneoff of $200m capital gain. This is a far cry from $70mil, 2 years ago.
With FDA approval early next year for HPV then a oneoff bonus payment from Merck comes in.
Are we looking at a cheap (PE) company as this one-off have not been factored in?
After all once HPV vaccine hits the market an extra 150-200m annual addition on profit is on the card as well...
____________________________________________
where are you pulling the $150 - 200 million from ?
singas
- Forums
- ASX - By Stock
- CSL
- buy buy buy buy buy -
buy buy buy buy buy - , page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$301.66 |
Change
1.790(0.60%) |
Mkt cap ! $146.0B |
Open | High | Low | Value | Volume |
$301.73 | $302.12 | $299.87 | $209.3M | 694.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1810 | $301.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$301.75 | 780 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1810 | 301.580 |
1 | 5 | 301.470 |
1 | 5 | 301.430 |
1 | 2908 | 301.410 |
1 | 74 | 301.230 |
Price($) | Vol. | No. |
---|---|---|
301.750 | 30 | 1 |
301.890 | 75 | 1 |
301.920 | 350 | 1 |
301.950 | 113 | 1 |
301.990 | 1200 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |